Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
Improving Skin Health: By potentially reducing inflammation and protecting cells from free radical damage, Glynac may support healthier skin, promoting elasticity and reducing signs of ageing for a radiant complexion
Fitness and wellness brands are moving from fat-burn to healthspan
Case studies and media articles have hinted at unexpected side effects of GLP-1 agonist medications, i.e
The enforcement backdrop is real: the US Food and Drug Administration (FDA) has acted against illegal marketing of compounded GLP-1 products, a reminder that framing a supplement as an equivalent to semaglutide or tirzepatide invites regulatory risk [7]